𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Functional characterization of theArabidopsis thaliananitrate transporter CHL1 in the yeastHansenula polymorpha

✍ Scribed by Yusé Martín; Francisco J. Navarro; José M. Siverio

Publisher
Springer
Year
2008
Tongue
English
Weight
408 KB
Volume
68
Category
Article
ISSN
0167-4412

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Functional characterization of human org
Functional characterization of human organic cation transporter OCTN1 single nucleotide polymorphisms in the Japanese population
✍ Yuki Kawasaki; Yukio Kato; Yoshimichi Sai; Akira Tsuji 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 1 views

The organic cation transporter OCTN1 (SLC22A4) is expressed ubiquitously, with strong expression in kidney, trachea, bone marrow, and fetal liver, and it mediates transport of organic cations in a pH-dependent manner. Recent studies have identified single nucleotide polymorphisms (SNPs) of OCTN1 in

Functional characterization of missense
Functional characterization of missense variants in the creatine transporter gene (SLC6A8): improved diagnostic application
✍ Efraim H. Rosenberg; Cristina Martínez Muñoz; Ofir T. Betsalel; Silvy J.M. van D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB

Creatine transporter deficiency is an X-linked mental retardation disorder caused by mutations in the creatine transporter gene (SLC6A8). So far, 20 mutations in the SLC6A8 gene have been described. We have developed a diagnostic assay to test creatine uptake in fibroblasts. Additionally, we expande

Functional characterization of rat plasm
Functional characterization of rat plasma membrane monoamine transporter in the blood–brain and blood–cerebrospinal fluid barriers
✍ Takashi Okura; Sayaka Kato; Yusuke Takano; Takenori Sato; Atsushi Yamashita; Riy 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 606 KB

This study investigated the expression and functional roles of rat plasma membrane monoamine transporter (rPMAT) in the blood-brain barrier (BBB) and the bloodcerebrospinal fluid barrier by using in vitro brain barrier model cells (TR-BBB13 and TR-CSFB3 cells) and multiple in vivo experimental techn